Complain about a product or service

Diabetes Drug May Help Treat Alzheimer's

July 21, 2006

• Daily Pill Said To Stop Alzheimer's • Low Levels of 'Good Cholesterol' Linked to Memory Loss, Dementia Risk • Chemical in Celery May Fight Alzheimer's • Dementia Linked To Obesity • Studies Find Link Between Diabetes and Alzheimer's • Lifestyle Linked to Alzheimer's Onset • Pot Belly in Middle Age Linked to Alzheimer's • 10 Million Boomers Face Alzheimer's • Alzheimer's Risk Higher in Victims' Children • Fast-Acting Alzheimer's Therapy Excites Researchers • Too Much Sugar May Increase Alzheimer’s Risk • Beta Carotene May Slow Memory Loss • Promising Alzheimer’s Discovery Reported • Misconceptions About Alzheimer's Vary Among Races • Mediterranean Diet May Extend Alzheimer’s Patients’ Lives • Researchers Link Smoking To Dementia • Caffeine May Keep Dementia At Bay In Women • Alzheimer’s Drug Seen As “Safe, Effective” • Researchers “A Step Closer” To Alzheimer’s Cure • FDA Approves Alzheimer’s Patch • Scientists Raise Hopes For Alzheimer's Vaccine • Researchers Hopeful About New Alzheimer’s Therapy • Blood Pressure Drugs May Provide Alzheimer’s Protection • Progress Toward Early Alzheimer's Diagnosis Reported • Alzheimer's Cases Up 10% In 5 Years • Loneliness Linked to Dementia • Gene Changes Identified in Alzheimer's • Mental Exercise May Help Seniors • Rote Learning Improves Memory in Seniors • Vegetables May Slow Memory Loss • Cabernet Sauvignon May Reduce Alzheimer's Risk • Fruit Juice May Reduce Alzheimer's Risk • Skin Test May Detect Alzheimer's Disease • Exercise May Prevent Dementia-Like Illnesses • An Apple A Day May Improve Memory • New Drug Reverses Alzheimer's Damage, Australian Researchers Report • Diabetes Drug May Help Treat Alzheimer's • For Women, Weight Loss May Precede Dementia • Researchers "Closer" To Preventing Alzheimer's • Statins Help Memory in Older Women • Study Links Healthy Diet To Reduced Alzheimer's Risk • Tea May Help Combat Alzheimer's • Education May Accelerate Alzheimer's Effects • Alzheimer's Found to be Mostly Genetic • Exercise May Reduce Risk of Dementia in Older People • Researchers Find DNA Link to Alzheimer's • Brain Scan, Fluid Analysis May Help Predict Alzheimer's • Eating Fish Associated With Slower Cognitive Decline • Word Recall An Alzheimer' s Tip-Off? • Interrupted Alzheimer's Trial Produced Promising Results • Gene Therapy May Offer Hope For Alzheimer's Patients • Alzheimer's Researchers Reverse Memory Loss in Mice • Alzheimer's Disease Reveals Itself Earlier, Study Finds

Researchers say treatment of high blood sugar may have a scientific connection to memory loss that could, one day, benefit millions of people with Alzheimer's Disease, which affects up to 4.5 million older Americans, bringing with it impaired thinking and memory.

New research at the University of Virginia Health System and Case Western Reserve University shows that a drug approved by the Food and Drug Administration to treat type 2 diabetes may hold promise in treating Alzheimer's as well, without serious side effects.

"We believe that the drug may reduce the body's inflammatory reaction to one of the toxic components that builds up in Alzheimer's, called amyloid plaque," said Dr. David Geldmacher, an associate professor of neurology at UVa.

The drug, called pioglitazone HCl, was tested in a placebo-controlled trial involving 25 people with mild to moderate Alzheimer's. The study assessed the safety of the drug and, although the treatment appeared to reduce Alzheimer's progression, the study was too small for investigators to be sure of the effects on memory and everyday abilities. However, the findings are promising enough, researchers say, to carry out larger studies of pioglitazone.

"We don't know exactly how pioglitazone works in Alzheimer's, but there are two possibilities," Geldmacher said. "It could be that the drug reduces the body's response to the amyloid protein found in Alzheimer's. Or, it could be that this drug helps brain cells function. The real advantage is that it's a completely novel approach to treating the disease."

In the next few years, Geldmacher and his colleagues hope to study the effectiveness of pioglitazone in a group of 200 to 300 Alzheimer's patients nationwide.

"If it works, this treatment might allow people to better hold on to memory and brain function over a period of time, despite having Alzheimer's," Geldmacher said. "It could also complement other treatments and become part of a multi-pronged approach to Alzheimer's treatment."

Right now, there are 5 drugs approved by the FDA to treat Alzheimer's, Geldmacher said, but pioglitazone is unrelated to any of the others. The trial of pioglitazone at UVa and Case Western Reserve was supported by the National Institutes of Health and Takeda Pharmaceuticals North America, Inc., which manufactures the drug.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.